M.A. Minassian scite author profile

The comparative in-vitro activity of CP-99219, a new quinolone, against Haemophilus influenzae (150 isolates), Moraxella catarrhalis (100), Streptococcus pneumoniae (80) and Group A beta-haemolytic streptococci (40) was determined using an agar dilution technique. CP-99219 was the most active compound tested against M. catarrhalis (MIC50 = 0.015 mg/L, MIC90 = 0.03 mg/L). Ceftriaxone, CP-99219 and ciprofloxacin were the three most active agents tested against H.influenzae. CP-99219 showed good activity, 16-fold greater than that of ciprofloxacin, against S.pneumoniae (MIC50 = 0.12 mg/L; MIC90 = 0.25 mg/L) and was also active against Group A streptococci. Clinical studies regarding the use of CP-99219 in respiratory tract infections seem indicated.

show abstract

A Comparison Between Single-Dose Fosfomycin Trometamol (Monouril [R]) and a 5-Day Course of Trimethoprim in the Treatment of Uncomplicated Lower Urinary Tract Infection in Women

Minassian

Lewis

Chattopadhyay

et al. 1999

Journal of Urology

View full text Add to dashboard Cite

The Americas region tackles antimicrobial resistance

Escati¹,

Minassian²,

Barcos³

2017

View full text Add to dashboard Cite

A Comparison Between Single-Dose Fosfomycin Trometamol (Monouril [R]) and a 5-Day Course of Trimethoprim in the Treatment of Uncomplicated Lower Urinary Tract Infection in Women

Minassian¹,

Lewis²,

Chattopadhyay³

et al. 1999

The Journal of Urology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

M.A. Minassian

A comparison between single-dose fosfomycin trometamol (Monuril®) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women

Melioidosis presenting as septic arthritis in Bengali men in East London

Imipenem for the treatment of melioidosis

Comparative in-vitro activity of CP-99219, a new quinolone, against respiratory pathogens

A Comparison Between Single-Dose Fosfomycin Trometamol (Monouril [R]) and a 5-Day Course of Trimethoprim in the Treatment of Uncomplicated Lower Urinary Tract Infection in Women

The Americas region tackles antimicrobial resistance

A Comparison Between Single-Dose Fosfomycin Trometamol (Monouril [R]) and a 5-Day Course of Trimethoprim in the Treatment of Uncomplicated Lower Urinary Tract Infection in Women

Contact Info

Product

Resources

About